Nevro Corp (NYSE:NVRO)
$ 5.06 -0.26 (-4.89%) Market Cap: 188.65 Mil Enterprise Value: 166.94 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 42/100

Nevro Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 09:30PM GMT
Release Date Price: $165 (-2.45%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Hi, everyone. Glad you made it all the way to almost the end of day 2 of the JPMorgan Healthcare Conference. We are not done and still have some great sessions left. I'm happy to introduce our next speaker, Keith Grossman, the CEO of Nevro.

Before I hand it over to Keith, just to remind everyone that you can access the slides on the conference website. You can go there to submit a question for me to ask in the Q&A or feel free to email me or chat me on Bloomberg.

And with that, Keith, I will turn it over to you and join you afterwards for Q&A.

D. Keith Grossman
Nevro Corp. - Chairman of the Board, CEO & President

Okay. All right. Thanks, Robbie, and thanks to all of you who are attending. Welcome. As I understand it, your -- for those of you following along on the slides, you're flipping through on your own. So I'll try to refer to page numbers as I go through our deck here.

So if you go with me to Slide 3. For those of you who might not be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot